Richard Pzena
Pzena Investment Management
Richard Pzena CVS Health Corp stake
total: 584
Pzena Investment Management CVS trades
- Total transactions:
- 36
- New positions:
- 2
- Sold out:
- 1
- Added:
- 21
- Reduced:
- 12
- Held since:
- 2023 Q4
- Held for:
- 11 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Richard Pzena holds 11,769,536 CVS Health Corp (CVS) shares with a market value of roughly $1.22B accounting for 3.57% of the overall portfolio. To date, the estimated cost basis is nearly $60.25 for "buy" trades and estimated average "sell" price is $79.23. Pzena Investment Management first purchased CVS in 2015 Q1, initially acquiring 527,165 shares. Richard Pzena later completely sold out the position and invested in CVS Health Corp again in 2023 Q4. Since the initial investment in CVS Health Corp (CVS), Pzena Investment Management has made 35 more transactions.
When did Richard Pzena buy CVS Health Corp (CVS)?
Richard Pzena first invested in CVS Health Corp (CVS) in 2015 Q1 at the reported quarter-end price of $103.21 per share.
What's the cost basis of Pzena Investment Management's CVS stake?
The estimated cost basis for CVS Health Corp (CVS) stake is around $60.25 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $60.25
- Weighted AVG sell price:
- $79.23
Richard Pzena's historical trades in CVS Health Corp
36 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
3.57%
|
11,769,536
|
$103.45
|
$1,217,558,500
|
-14.55% (-2,003,517)
|
-0.67%
|
|
2026 Q1
|
3.21%
|
13,773,053
|
$71.82
|
$989,180,667
|
-11.61% (-1,808,254)
|
-0.39%
|
|
2025 Q4
|
3.70%
|
15,581,307
|
$79.36
|
$1,236,532,523
|
-1.66% (-263,665)
|
-0.07%
|
|
2025 Q3
|
3.86%
|
15,844,972
|
$75.39
|
$1,194,552,439
|
-5.39% (-901,881)
|
-0.22%
|
|
2025 Q2
|
3.76%
|
16,746,853
|
$68.98
|
$1,155,197,920
|
-5.29% (-935,521)
|
-0.23%
|
|
2025 Q1
|
4.18%
|
17,682,374
|
$67.75
|
$1,197,980,839
|
-9.83% (-1,928,205)
|
-0.44%
|
|
2024 Q4
|
3.00%
|
19,610,579
|
$44.89
|
$880,318,891
|
+49.30% (+6,475,271)
|
+0.99%
|
|
2024 Q3
|
2.66%
|
13,135,308
|
$62.88
|
$825,948,167
|
+1.54% (+198,920)
|
+0.04%
|
|
2024 Q2
|
2.69%
|
12,936,388
|
$59.06
|
$764,023,075
|
+132.94% (+7,382,931)
|
+1.53%
|
|
2024 Q1
|
1.52%
|
5,553,457
|
$79.76
|
$442,943,731
|
+573.76% (+4,729,207)
|
+1.29%
|
|
2023 Q4
|
0.24%
|
$78.96
|
new
|
|||
|
2021 Q3
|
0.00%
|
$83.44
|
-100% (-1,235,580)
|
|||
|
2021 Q2
|
0.40%
|
$83.44
|
+0.04% (+527)
|
|||
|
2021 Q1
|
0.38%
|
$75.23
|
+0.09% (+1,078)
|
|||
|
2020 Q4
|
0.40%
|
$68.30
|
+6.52% (+75,581)
|
|||
|
2020 Q3
|
0.42%
|
$58.40
|
+3.89% (+43,418)
|
|||
|
2020 Q1
|
0.50%
|
$59.33
|
+17.15% (+163,186)
|
|||
|
2019 Q4
|
0.33%
|
$74.29
|
-0.01% (-132)
|
|||
|
2019 Q3
|
0.33%
|
$63.07
|
+33.00% (+236,189)
|
|||
|
2019 Q2
|
0.21%
|
$54.49
|
-0.44% (-3,151)
|
|||
|
2019 Q1
|
0.21%
|
$53.93
|
+0.07% (+502)
|
|||
|
2018 Q4
|
0.28%
|
$65.52
|
-0.10% (-698)
|
|||
|
2018 Q3
|
0.28%
|
$78.72
|
-0.51% (-3,706)
|
|||
|
2018 Q2
|
0.23%
|
$64.35
|
+2.72% (+19,145)
|
|||
|
2018 Q1
|
0.22%
|
$62.21
|
+0.37% (+2,559)
|
|||
|
2017 Q4
|
0.25%
|
$72.50
|
+0.17% (+1,210)
|
|||
|
2017 Q3
|
0.30%
|
$81.32
|
-0.03% (-202)
|
|||
|
2017 Q2
|
0.31%
|
$80.46
|
+31.09% (+166,039)
|
|||
|
2017 Q1
|
0.24%
|
$78.50
|
+0.05% (+287)
|
|||
|
2016 Q4
|
0.24%
|
$78.91
|
+0.73% (+3,890)
|
|||
|
2016 Q3
|
0.29%
|
$88.99
|
-0.00% (-26)
|
|||
|
2016 Q2
|
0.32%
|
$95.74
|
+0.23% (+1,225)
|
|||
|
2016 Q1
|
0.34%
|
$103.73
|
+0.24% (+1,270)
|
|||
|
2015 Q4
|
0.32%
|
$97.77
|
+0.02% (+124)
|
|||
|
2015 Q2
|
0.31%
|
$104.88
|
+0.02% (+100)
|
|||
|
2015 Q1
|
0.30%
|
$103.21
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.